Document Type
Article
Department
Obstetrics and Gynaecology (East Africa)
Abstract
Cancer remains a leading cause of morbidity and mortality in people with HIV, and the importance of cancer screening increasesas this population ages. In 2017, 2020, and 2023, cross-sectional surveys were conducted at HIV care sites across 5 continentswithin the International epidemiology Databases to Evaluate AIDS (IeDEA) consortium. We described cancer screening avail-ability in 2023 and over time for cervical and anal cancer screening using generalized estimating equations with a logit linkfunction to account for site clustering, rurality, and country income. Of the 220 sites in the 2023 survey, 61% (134/220) reportedcervical cancer screening by cytology or human papillomavirus (HPV) testing on-site, and 88% (194/220) reported cervical can-cer screening by any method, including visual inspection. At sites serving predominantly rural populations, 62% (29/47) exclu-sively performed screening by visual inspection. Overall, 23% (50/220) of sites performed cytology-based anal cancer screeningon-site, and 16% (35/220) had availability of high-resolution anoscopy, either on-site or by referral. Screening for cancer of theliver, colon, lung, prostate, or breast (by imaging) were each available at less than 43% of sites. The odds of cervical cancer screen-ing availability increased by 16% annually from 2017 through 2023 (aOR = 1.16, 95% CI: 1.07–1.27, p = 0.001), while the relativeodds of anal cancer screening availability decreased by 9% annually (aOR = 0.91, 95% CI: 0.84–0.99, p = 0.023). Lack of trainedstaff was the most frequently reported barrier, followed by lack of equipment. Understanding current practices and capacity isessential for the continued integration of cancer prevention in HIV care.
Publication (Name of Journal)
International Journal of Cancer
DOI
https://doi.org/10.1002/ijc.70503
Recommended Citation
Pellegrino, R.,
Shepherd, B.,
Pujari, S.,
Fink, V.,
Murenzi, G.,
Nakalembe, M.,
Coburn, S.,
Rohner, E.,
Jaquet, A.,
Orang'o, E.
(2026). Availability of cancer screening across HIV treatment sites in the IeDEA consortium. International Journal of Cancer, 1-13.
Available at:
https://ecommons.aku.edu/eastafrica_fhs_mc_obstet_gynaecol/781
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.